MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME

Bibliografski detalji
Glavni autori:	Boultwood, J, Fidler, C, Lewis, S, Maccarthy, A, Kelly, S, Sheridan, H, Littlewood, T, Buckle, V, Wainscoat, J
Format:	Journal article
Izdano:	1993

Slični predmeti

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
od: Boultwood, J, i dr.
Izdano: (1993)

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
od: Boultwood, J, i dr.
Izdano: (1994)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (1993)

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
od: Jaju, R, i dr.
Izdano: (1998)

ISOLATION OF NOVEL CDNA CLONES MAPPING TO THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
od: Boultwood, J, i dr.
Izdano: (1994)

The 5q-syndrome.
od: Boultwood, J, i dr.
Izdano: (1994)

MOLECULAR MAPPING OF THE 7Q-DELETION IN MYELOID DISORDERS
od: Lewis, S, i dr.
Izdano: (1993)

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome.
od: Fidler, C, i dr.
Izdano: (1999)

Narrowing the critical deleted region in the 5q-syndrome.
od: Jaju, R, i dr.
Izdano: (1996)

5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (2012)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
od: Lewis, S, i dr.
Izdano: (1995)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
od: Fidler, C, i dr.
Izdano: (2004)

Narrowing and genomic annotation of the critical region of the 5q-syndrome.
od: Boultwood, J, i dr.
Izdano: (2000)

Homozygous deletion of FMS in a patient with the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (1990)

The 5q- syndrome.
od: Giagounidis, A, i dr.
Izdano: (2004)

Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene.
od: Boultwood, J, i dr.
Izdano: (2000)

Advances in the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (2010)

Molecular analysis of the 5q-syndrome
od: Boultwood, J
Izdano: (2007)

Primary transcription map of the critical region of the 5q-syndrome.
od: Boultwood, J, i dr.
Izdano: (1996)

Novel genes mapping to the critical region of the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (1997)

Isolation and analysis of novel candidate genes mapping to the critical region of the 5q-syndrome.
od: Boultwood, J, i dr.
Izdano: (1999)

Molecular characterization of the 7q deletion in myeloid disorders.
od: Lewis, S, i dr.
Izdano: (1996)

Mutation analysis of the SPARC gene in the 5q-syndrome.
od: Fidler, C, i dr.
Izdano: (2000)

Isolation and analysis of novel genes mapping to the critical region of the 5q-syndrome
od: Fidler, C, i dr.
Izdano: (1998)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
od: Pellagatti, A, i dr.
Izdano: (2003)

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (2002)

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
od: Jaju, R, i dr.
Izdano: (2000)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (2012)

Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs.
od: Boultwood, J, i dr.
Izdano: (2000)

RECENT ADVANCES IN THE 5Q- SYNDROME
od: Andrea Pellagatti, i dr.
Izdano: (2015-05-01)

Molecular characterization of the chromosome 9q deletion in AML.
od: Side, L, i dr.
Izdano: (2000)

Molecular diagnosis of the 5q deletion in malignant myeloid disorders.
od: Boultwood, J
Izdano: (1996)

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome.
od: Boultwood, J
Izdano: (2011)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (2007)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
od: Boultwood, J, i dr.
Izdano: (2013)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
od: Pellagatti, A, i dr.
Izdano: (2004)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
od: Pellagatti, A, i dr.
Izdano: (2008)

Whole chromosome painting and FISH with subtelomeric probes reveals cryptic chromosome rearrangements in del(5q) leukaemias: a UK Cancer Cytogenetic Group study
od: Kearney, L, i dr.
Izdano: (1999)

A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood AML.
od: Jaju, R, i dr.
Izdano: (1998)

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome
od: Jacqueline Boultwood
Izdano: (2011-06-01)